Study details
Enrolling now
Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
University of Maryland, Baltimore
NCT IDNCT05440214ClinicalTrials.gov data as of Apr 2026
Target enrollment
68
Study length
about 4.1 years
Ages
18+
Locations
1 site in MD
What this study is about
This trial is testing a treatment that targets emotion dysregulation in people with psychotic disorders. The goal is to see if this intervention can reduce suicide risk in this population.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Dialectical Behavior Therapy Skills Training
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Psychiatry / Mental Health